Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03. - Garcia-Donas J; Hurtado A; Garrigos L; Santaballa A; Redondo A; Vidal L; Lainez N; Guerra E; Rodriguez V; Cueva J; Bover I; Palacio I; et al. (Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2023)